Northwestern University
Chicago, Illinois, 60611, United States
Location status: Recruiting
Location contact
Amy E Krambeck, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07631286
The objective of this study is to compare a new surgical technique for HoLEP that will allow for sparing of ejaculation post-HoLEP.
Interested in participating?
Request Info18 year–100 year
Male
Interventional
Not applicable
Chicago, Illinois, 60611, United States
Location status: Recruiting
Amy E Krambeck, MD
PRINCIPAL_INVESTIGATOR
The primary aim of this study is to assess the efficacy of ejaculatory-sparing HoLEP (ES-HoLEP) in preserving ejaculation while also maintaining good urinary outcomes.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The ejaculatory sparing technique involves sparing the distal apex of the prostate in particular the anterior portion of the prostate which will allow for coaptation necessary for antegrade ejaculation.
Time frame: 1 year
Patient reported incidence of experiencing retrograde ejaculation
Time frame: 1 year
Patient reported satisfaction of ejaculation using Male Sexual Health Questionnaire - Ejaculatory Dysfunction (MSHQ-EjD) questionnaire. The MSHQ-EjD-SF evaluates the following parameters in regards to ejaculation: Frequency, Force, Volume and Bother (How much are you bothered by any ejaculation difficulties) on a 6-point Likert scale (typically scored 0 to 5).
Interpretation: Higher scores indicate better ejaculatory function, while lower scores denote dysfunction and a greater level of personal distress regarding one's ejaculatory function.
Time frame: 1 year
Patient reported sexual satisfaction using the Sexual Health Inventory for Men (SHIM) questionnaire.
The Sexual Health Inventory for Men (SHIM) contains 5 questions that is individually scored on a scale of 0 to 5. The SHIM score is calculated by adding up the scores of the 5 individual questions.
Interpretation: Higher scores indicate better erectile function, while lower scores denote erectile dysfunction. A total score of 21 or less indicates that erectile dysfunction is present and should be addressed with a healthcare provider.
Time frame: 1 year
Patient reported urinary satisfaction using the International Prostate Symptom Score (IPSS) questionnaire.
The International Prostate Symptom Score (IPSS) is calculated by asking patients to rate 7 urinary symptoms over the past month on a scale from 0 to 5. These scores are simply added together to yield a total symptom severity score ranging from 0 to 35.
An 8th question measures overall Quality of Life (QoL) but is not factored into the numerical total.
Interpretation: the total score range is from 0 to 35.
The total score indicates symptom severity:
0-7: Mildly symptomatic 8-19: Moderately symptomatic 20-35: Severely symptomatic
Time frame: 1 year
Patient reported urinary satisfaction using the Michigan Incontinence Symptom Index (M-ISI) questionnaires.
The M-ISI (Michigan Incontinence Symptom Index) questionnaire is a 10-item clinical tool used to evaluate the severity of urinary incontinence and how much it bothers the patient. It is calculated by assigning scores (0 to 4) to each answer and summing them across two primary domains.
Total M-ISI Severity Domain (Items 1-8): Sum of the scores for the first 8 questions. This evaluates incontinence subdomains (Stress Urinary Incontinence, Urgency Urinary Incontinence, and Pad Use). Possible score range 0 to 32.
Bother Domain (Items 9-10): Sum of the scores for questions 9 and 10. This measures the emotional and physical impact of the leakage. Possible score range 0 to 8.
Interpretation: Higher scores indicate the individual is likely incontinent or has experience with incontinence.
Contact information is provided by the study sponsor or research team.
Northwestern University
Other
Ejaculatory-sparing Holmium Laser Enucleation of the Prostate (HoLEP) vs Standard HoLEP: a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07580404
Benign Prostatic Hyperplasia, Enlarged Prostate (BPH)
Chicago, Illinois, United States
View Trial DetailsNCT07632742
Benign Prostatic Hyperplasia, Enlarged Prostate (BPH)
Chicago, Illinois, United States
View Trial DetailsNCT05330520
BOO - Bladder Outflow Obstruction, BPH
Petah Tikva, Israel
View Trial DetailsNCT03055624
Enlarged Prostate With Lower Urinary Tract Symptoms, Genital Diseases
San Diego, California, United States
View Trial Details